Distinct skin microbiome modulation following different topical acne treatments in mild acne vulgaris patients: A randomized, investigator‐blinded exploratory study
Experimental Dermatology · 2023-06 · 32 (6) · 906-914
DOI: 10.1111/exd.14779 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Experimental Dermatology, online erschienen am 18.03.2023. Verfasst von Chanidapa Wongtada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Dermatology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Acne Vulgaris, Microbiota. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
The effects of topical non‐antibiotic acne treatment on skin microbiota have rarely been demonstrated. In the study, we randomized 45 mild acne vulgaris participants into three treatment groups, including a cream‐gel dermocosmetic containing Aqua Posae Filiformis, lipohydroxy acid, salicylic acid, linoleic acid, niacinamide and piroctone olamine (DC), retinoic acid 0.025% cream (VAA) and benzoyl peroxide 2.5% gel (BP). At months 0, 1 and 3, skin specimens were swabbed from the cheek and forehead and sequenced by targeting V3‐V4 regions of the 16 S rRNA gene. QIIME2 was used to characterize bacterial communities. Acne severity, sebum level and tolerability were assessed concomitantly in each visit. We found that both VAA and BP could significantly reduce the bacterial diversity at month 1 ( p ‐value = 0.010 and 0.004 respectively), while no significant reduction was observed in DC group. The microbiota compositions also significantly altered for beta diversity in all treatments (all p ‐value = 0.001). An increased Cutibacterium with decreased Staphylococcus relative abundance was observed at months 1 and 3 in DC group, while an opposite trend was demonstrated in VAA and BP groups. These findings suggest a potential impact of DC, VAA and BP on the diversity and composition profiles of the skin microbiota in mild acne participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Dermatology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
- Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Antimicrobial Resistance and Stewardship Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Chanidapa Wongtada
Zitieren
APA
Wongtada, C., Prombutara, P., Asawanonda, P., Noppakun, N., Kumtornrut, C., & Chatsuwan, T. (2023). Distinct skin microbiome modulation following different topical acne treatments in mild acne vulgaris patients: A randomized, investigator‐blinded exploratory study. Experimental Dermatology, 32(6), 906-914. https://doi.org/10.1111/exd.14779
Vancouver
Wongtada C, Prombutara P, Asawanonda P, Noppakun N, Kumtornrut C, Chatsuwan T. Distinct skin microbiome modulation following different topical acne treatments in mild acne vulgaris patients: A randomized, investigator‐blinded exploratory study. Experimental Dermatology. 2023;32(6):906-914. doi:10.1111/exd.14779
BibTeX
@article{Wongtada2023,
author = {Wongtada, Chanidapa and Prombutara, Pinidphon and Asawanonda, Pravit and Noppakun, Nopadon and Kumtornrut, Chanat and Chatsuwan, Tanittha},
title = {Distinct skin microbiome modulation following different topical acne treatments in mild acne vulgaris patients: A randomized, investigator‐blinded exploratory study},
journal = {Experimental Dermatology},
year = {2023},
volume = {32},
number = {6},
pages = {906--914},
doi = {10.1111/exd.14779}
}
EUVIMED